effects [qlco]
Raloxifene [orch, phsu]
Body Fat Distribution [fndg]
Lipid [lipd]
Profile [lbpr]
Health [idcn]
Post-Menopause [orgf]
Women [popg]
Aim [idcn]
prospective [resa]
Controlled [ftcn]
Open Label Study [resa]
Clinical [qlco]
To [qlco]
Evaluate [ftcn]
Health [idcn]
Post-Menopause [orgf]
Women [popg]
effects [qlco]
Raloxifene [orch, phsu]
Body Fat Distribution [fndg]
Lipids [lipd]
Correlation [qlco]
Parameters [fndg]
distribution [idcn]
Dual-Energy X-Ray Absorptiometry [diap]
Lipids [lipd]
Evaluated [ftcn]
baseline [bodm]
yr [tmco]
postmenopausal [tmco]
Women [popg]
treated [topp]
Expired [orgf]
Control Group [grup]
yr [tmco]
Observed [ftcn]
Raloxifene [orch, phsu]
Users [humn]
Slight [qlco]
reduction [npop]
Mass [fndg]
Trunk [blor]
Central region [geoa]
Increase [ftcn]
Legs [blor]
Control Group [grup]
Lower [spco]
Values [qlco]
adiposity [dsyn]
Trunk [blor]
Abdominal region [blor]
P NOS [aapp, imft]
Same [qlco]
Time [tmco]
Cholesterol [bacs, strd]
Apolipoprotein A-I [aapp, bacs]
Increased [qnco]
baseline [bodm]
Values [qlco]
Control Group [grup]
P NOS [aapp, imft]
Apolipoprotein B [aapp, bacs]
Total Cholesterol [lbpr]
Cholesterol, LDL [bacs, strd]
Apolipoprotein B/Apolipoprotein A-I [aapp]
Ratios [qnco]
Decreased [qnco]
Compared [acty]
baseline [bodm]
Values [qlco]
Control Group [grup]
P NOS [aapp, imft]
Correlation [qlco]
Lipids [lipd]
regional [spco]
distribution [idcn]
Result [ftcn]
Effect [qlco]
Raloxifene [orch, phsu]
Lipids [lipd]
Suggest [idcn]
First [qnco]
Time [tmco]
Raloxifene [orch, phsu]
Promote [acty]
Shift [ftcn]
Android [mnob]
Gynoid fat distribution [fndg]
PREVENT [phsu]
Abdominal [blor]
adiposity [dsyn]
Body Weight [orga]
Compared [acty]
untreated [fndg]
Women [popg]
